Challenges and perspectives in preventing and treating obesity
Resumo
The American Medical Association recognized obesity as a chronic disease in 2013, followed by the World Health Organization. At that time, the global incidence and prevalence of obesity had already been progressively increasing for at least three decades. This scenario has not changed; recent data estimate that 1 billion people worldwide will be obese by 2030. The Brazilian Institute of Geography and Statistics has reported that 25% of the adult Brazilian population lives with the disease, a percentage that has quadrupled in children and adolescents since the 1990s.
Downloads
Referências
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(1040):2133-61. PMID: 38642570; https://doi.org/10.1016/s0140-6736(24)00757-8.
Syn NL, Cummings DE, Wang LZ, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397(10287):1830-41. PMID: 33965067; https://doi.org/10.1016/s0140-6736(21)00591-2.
Instituto de Estudos de Saúde Suplementar. Como o aumento da prevalência da obesidade entre beneficiários pode impactar a sustentabilidade da saúde suplementar. São Paulo: IESS; 2022. Available from: https://www.iess.org.br/sites/default/files/2022-06/ Obesidade_Cen%C3%A1rios%20para%20o%20Futuro.pdf. Accessed in 2024 (Jun. 14).
Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes. 2009;33(3):289-95. PMID: 19188927; https://doi.org/10.1038/ ijo.2009.2.
Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Obes Surg. 2023;33(1):3-14. PMID: 36336720; https://doi.org/10.1007/s11695-022-06332-1.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 São Paulo Medical Journal

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.